Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple cytokine and neurotrophic signaling pathways represent a broad regulatory network that integrates immune system signals with neuronal growth and survival factors. Cytokines, such as interleukins and interferons, typically mediate inflammatory responses, while neurotrophic factors like brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) support the development and maintenance of the nervous system (Duman & Monteggia, 2006, PubMed: 16531991). These pathways are deeply interconnected; for instance, chronic neuroinflammation driven by pro-inflammatory cytokines can suppress neurotrophic support, leading to neurodegeneration or psychiatric disorders like major depression (Miller et al., 2009, PubMed: 19426289). Drugs targeting these pathways, such as Cerebrolysin or certain pleiotropic antidepressants, often aim to exert neuroprotective effects by either inhibiting inflammatory signaling or enhancing neurotrophic signaling (Plosker & Gauthier, 2012, PubMed: 22512327). Because this 'target' encompasses a wide array of receptors and intracellular messengers rather than a single molecular entity, it is considered a descriptive category of biological processes rather than a specific therapeutic target. Therapeutic intervention in these pathways requires careful calibration to restore homeostatic balance in the central nervous system without causing broad systemic side effects.
Modulation of diverse intracellular signaling cascades, such as the JAK/STAT, PI3K/Akt, and MAPK/ERK pathways, to balance pro-inflammatory signals and enhance neurotrophic support.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cytokine and neurotrophic signaling pathways.